ROIVANT SCIENCES LTD. Stock Issued During Period, Value, Employee Stock Purchase Plan
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- ROIVANT SCIENCES LTD. stock issued during period, value, employee stock purchase plan for the quarter ending 2026-06-30 was $635.00K.
- ROIVANT SCIENCES LTD. stock issued during period, value, employee stock purchase plan for the quarter ending 2025-12-31 was $381.00K.
- ROIVANT SCIENCES LTD. stock issued during period, value, employee stock purchase plan for the quarter ending 2025-09-30 was $774.00K, a 19.44% increase year-over-year.
- ROIVANT SCIENCES LTD. stock issued during period, value, employee stock purchase plan for the quarter ending 2024-09-30 was $648.00K, a 10.39% increase year-over-year.
- ROIVANT SCIENCES LTD. stock issued during period, value, employee stock purchase plan for fiscal 2026 was $1.16M, a 12.35% increase from fiscal 2025.
- ROIVANT SCIENCES LTD. stock issued during period, value, employee stock purchase plan for fiscal 2025 was $1.03M, a 8.10% increase from fiscal 2024.
- ROIVANT SCIENCES LTD. stock issued during period, value, employee stock purchase plan for fiscal 2024 was $951.00K, a 200.95% increase from fiscal 2023.
- ROIVANT SCIENCES LTD. stock issued during period, value, employee stock purchase plan for fiscal 2023 was $316.00K.
| Period end | Stock Issued During Period, Value, Employee Stock Purchase Plan 3 month | Stock Issued During Period, Value, Employee Stock Purchase Plan 12 month |
|---|---|---|
| 2026-06-30 | $635.00K 10-Q · filed 2026-08-06 | |
| 2026-03-31 | $1.16M 10-K · filed 2026-05-20 | |
| 2025-12-31 | $381.00K 10-Q · filed 2026-02-06 | |
| 2025-09-30 | $774.00K 10-Q · filed 2026-02-06 | |
| 2025-03-31 | $1.03M 10-K · filed 2026-05-20 | |
| 2024-09-30 | $648.00K 10-Q · filed 2026-02-06 | |
| 2024-03-31 | $951.00K 10-K · filed 2026-05-20 | |
| 2023-09-30 | $587.00K 10-Q · filed 2025-02-10 | |
| 2023-03-31 | $316.00K 10-K · filed 2025-05-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |